Goldman Sachs’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.08M Buy
138,478
+33,663
+32% +$2.21M ﹤0.01% 2341
2025
Q1
$7.4M Buy
104,815
+4,815
+5% +$340K ﹤0.01% 2450
2024
Q4
$6.57M Buy
100,000
+29,374
+42% +$1.93M ﹤0.01% 2647
2024
Q3
$4.99M Buy
70,626
+49,829
+240% +$3.52M ﹤0.01% 2760
2024
Q2
$1.38M Buy
20,797
+6,635
+47% +$440K ﹤0.01% 3429
2024
Q1
$962K Sell
14,162
-26,284
-65% -$1.78M ﹤0.01% 3643
2023
Q4
$2.5M Sell
40,446
-30,312
-43% -$1.87M ﹤0.01% 3071
2023
Q3
$4.17M Buy
70,758
+5,463
+8% +$322K ﹤0.01% 2604
2023
Q2
$3.9M Sell
65,295
-159
-0.2% -$9.49K ﹤0.01% 2743
2023
Q1
$3.82M Buy
65,454
+159
+0.2% +$9.29K ﹤0.01% 2734
2022
Q4
$4.05M Buy
65,295
+40,209
+160% +$2.49M ﹤0.01% 2780
2022
Q3
$1.42M Sell
25,086
-63,696
-72% -$3.6M ﹤0.01% 3599
2022
Q2
$5.67M Buy
88,782
+63,825
+256% +$4.08M ﹤0.01% 2558
2022
Q1
$1.62M Buy
+24,957
New +$1.62M ﹤0.01% 3733
2021
Q4
Sell
-9,108
Closed -$556K 5593
2021
Q3
$556K Hold
9,108
﹤0.01% 4331
2021
Q2
$564K Buy
9,108
+2,946
+48% +$182K ﹤0.01% 4364
2021
Q1
$365K Buy
6,162
+162
+3% +$9.6K ﹤0.01% 4536
2020
Q4
$359K Hold
6,000
﹤0.01% 4001
2020
Q3
$327K Sell
6,000
-10,014
-63% -$546K ﹤0.01% 3855
2020
Q2
$821K Buy
16,014
+9,000
+128% +$461K ﹤0.01% 3340
2020
Q1
$315K Sell
7,014
-300,000
-98% -$13.5M ﹤0.01% 3724
2019
Q4
$16.4M Sell
307,014
-1,350,000
-81% -$72.1M ﹤0.01% 1744
2019
Q3
$77.2M Buy
1,657,014
+1,200,000
+263% +$55.9M 0.02% 744
2019
Q2
$23M Buy
457,014
+450,000
+6,416% +$22.6M 0.01% 1489
2019
Q1
$360K Buy
+7,014
New +$360K ﹤0.01% 3680
2018
Q3
Sell
-13,839
Closed -$698K 4173
2018
Q2
$698K Hold
13,839
﹤0.01% 3371
2018
Q1
$681K Hold
13,839
﹤0.01% 3353
2017
Q4
$712K Sell
13,839
-3,039
-18% -$156K ﹤0.01% 3295
2017
Q3
$880K Sell
16,878
-150,000
-90% -$7.82M ﹤0.01% 3285
2017
Q2
$8.63M Sell
166,878
-2,322
-1% -$120K ﹤0.01% 2003
2017
Q1
$8.51M Sell
169,200
-2,946
-2% -$148K ﹤0.01% 1933
2016
Q4
$8.12M Buy
172,146
+20,814
+14% +$981K ﹤0.01% 1918
2016
Q3
$7.54M Sell
151,332
-150,558
-50% -$7.5M ﹤0.01% 2004
2016
Q2
$14.5M Buy
301,890
+207
+0.1% +$9.96K ﹤0.01% 1567
2016
Q1
$13.8M Sell
301,683
-448,740
-60% -$20.5M ﹤0.01% 1563
2015
Q4
$40.4M Buy
750,423
+599,472
+397% +$32.3M 0.01% 1012
2015
Q3
$7.45M Sell
150,951
-3,795
-2% -$187K ﹤0.01% 1787
2015
Q2
$9.02M Buy
154,746
+4,002
+3% +$233K ﹤0.01% 1737
2015
Q1
$8.66M Sell
150,744
-2,538
-2% -$146K ﹤0.01% 1742
2014
Q4
$7.74M Buy
153,282
+33,267
+28% +$1.68M ﹤0.01% 1729
2014
Q3
$5.62M Sell
120,015
-6,762
-5% -$316K ﹤0.01% 1908
2014
Q2
$5.71M Buy
126,777
+45,885
+57% +$2.07M ﹤0.01% 1915
2014
Q1
$3.42M Buy
80,892
+44,916
+125% +$1.9M ﹤0.01% 2248
2013
Q4
$1.42M Buy
35,976
+24,564
+215% +$967K ﹤0.01% 2856
2013
Q3
$405K Buy
+11,412
New +$405K ﹤0.01% 3438